A7A-18216-93336
2 vaccinations
9 coded responses
15 check-ins
9 free-text entries
5 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 945 / CA
- Registered
- 2021-04-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-05
Dose 1 — Pfizer-BioNTech
-
2021-04-25
Registered in v-safe
-
2021-04-26
Survey response — day 21, dose 1MedDRA: Dyspnoea, Influenza virus test negative, Oropharyngeal pain, Pneumonia, SARS-CoV-2 test negative — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Suspected beginning pneumonia (xray, treated with antibiotics), trouble breathing, severe chest pain, potential costochondritis. Tested negative for COVID-19 and flu.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-26
Report sent to call center — day 21, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-03
Dose 2 — Pfizer-BioNTech
-
2021-05-04
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-06
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetite, Dyspnoea — Feeling: Fair · Site: Pain · Joint pains · Be unable to do your normal daily activitiesFree text: Trouble breathing, no appetiteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-07
Survey response — days 1–6 daily, dose 2MedDRA: Chest pain, Dyspnoea, Intermenstrual bleeding, Menstrual disorder — Feeling: Fair · Site: Pain · Headache, Joint pains, Abdominal pain · Be unable to do your normal daily activitiesFree text: Menstrual spotting, too early in cycle, also some trouble breathing and chest painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-08
Survey response — days 1–6 daily, dose 2MedDRA: Chest pain — Feeling: Fair · Site: Pain · Joint pains · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Chest painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-08
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-09
Survey response — days 1–6 daily, dose 2MedDRA: Chest pain, Dyspnoea, Intermenstrual bleeding — Feeling: Fair · Muscle or body aches · Be unable to do your normal daily activitiesFree text: Menstrual spotting, chest pain and trouble breathingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-10
Survey response — day 7, dose 2MedDRA: Intermenstrual bleeding — Feeling: Fair · Joint pains, Abdominal pain · Be unable to do your normal daily activitiesFree text: Menstrual spottingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-17
-
2021-05-24
Survey response — day 21, dose 2MedDRA: Chest discomfort, Chest pain, Gastrointestinal disorder — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Constant chest pressure, ache inside chest, abdominal issuesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-24
Report sent to call center — day 21, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-31
-
2021-06-09
Survey response — day 35, dose 2MedDRA: Chest pain, Dyspnoea, Heart rate increased — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Elevated heart rate (continued), still chest pain and trouble breathingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-09
Report sent to call center — day 35, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-06-14
Survey response — day 42, dose 2MedDRA: Chest pain — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Lung sensitivity, chest painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-14
Report sent to call center — day 42, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-06-17
- 2021-08-04
- 2021-11-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-05 | Pfizer-BioNTech | |
| 2 | 2021-05-03 | Pfizer-BioNTech |
Call center
5 call center cases
5 unsuccessful
Free text
Release 8 — day 21, dose 1
Symptoms: Suspected beginning pneumonia (xray, treated with antibiotics), trouble breathing, severe chest pain, potential costochondritis. Tested negative for COVID-19 and flu.
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Trouble breathing, no appetite
Systemic reaction (other): Menstrual spotting, too early in cycle, also some trouble breathing and chest pain
Systemic reaction (other): Chest pain
Systemic reaction (other): Menstrual spotting, chest pain and trouble breathing
Release 8 — day 7, dose 2
Systemic reaction (other): Menstrual spotting
Release 8 — day 21, dose 2
Symptoms: Constant chest pressure, ache inside chest, abdominal issues
Release 9 — day 35, dose 2
Symptoms: Elevated heart rate (continued), still chest pain and trouble breathing
Release 9 — day 42, dose 2
Symptoms: Lung sensitivity, chest pain
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chest discomfort | ✓ | ✓ | ✓ |
| SD | Chest pain | ✓ | ✓ | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Gastrointestinal disorder | ✓ | ✓ | ✓ |
| SD | Heart rate increased | ✓ | ✓ | ✓ |
| SD | Influenza virus test negative | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pneumonia | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
| SRO | Chest pain | ✓ | ✓ | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Intermenstrual bleeding | ✓ | ✓ | ✓ |
| SRO | Menstrual disorder | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release